{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T09:40:17Z","timestamp":1683711617363},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.nucmedbio.2006.10.013","type":"journal-article","created":{"date-parts":[[2007,1,6]],"date-time":"2007-01-06T12:11:19Z","timestamp":1168085479000},"page":"99-107","source":"Crossref","is-referenced-by-count":1,"title":["Validation of 8-[123I]iodo-l-1,2,3,4-tetrahydro-7-hydroxyisoquinoline-3-carboxylic acid as an imaging agent for prostate cancer in experimental models of human prostate cancer"],"prefix":"10.1016","volume":"34","author":[{"given":"Samuel","family":"Samnick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Nestle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Fozing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Menger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl-Martin","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2006.10.013_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.urology.2003.10.013","article-title":"Epidemiology of prostate cancer","volume":"62","author":"Crawford","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib2","series-title":"Cancer facts and figures 2003","year":"2003"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib3","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0959-8049(01)00267-2","article-title":"Cancer burden in the year 2000. The global picture","volume":"37","author":"Parkin","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2214\/ajr.176.1.1760017","article-title":"Prostate cancer: what is the future role for imaging?","volume":"176","author":"Thombury","year":"2001","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib5","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1007\/s00330-002-1389-z","article-title":"Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis","volume":"12","author":"Engelbrecht","year":"2002","journal-title":"Eur Radiol"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000085661","article-title":"Prostate cancer relapse after therapy with curative intention: a diagnostic and therapeutic dilemma","volume":"28","author":"Gronau","year":"2005","journal-title":"Onkologie"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1464-410X.2004.04927.x","article-title":"Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated?","volume":"94","author":"Gomez","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0090-4295(00)00896-7","article-title":"Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer","volume":"57","author":"Liu","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib9","first-page":"990","article-title":"PET imaging of prostate cancer using carbon-11-choline","volume":"39","author":"Hara","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib10","first-page":"187","article-title":"Development of (18)F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging","volume":"43","author":"Hara","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib11","first-page":"110","article-title":"Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer","volume":"61","author":"DeGrado","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib12","first-page":"556","article-title":"PET imaging of prostate cancer with 11C-acetate","volume":"44","author":"Dimitrakopoulou-Strauss","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib13","first-page":"549","article-title":"11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse","volume":"44","author":"Oyama","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00259-003-1377-9","article-title":"Kinetics of [(11)C]choline uptake in prostate cancer: a PET study","volume":"31","author":"Sutinen","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.apradiso.2005.12.002","article-title":"Preparation and tumor affinity testing of the radioiodinated tetrahydroisoquinoline derivative [123I]TIC(OH) for targeting prostate cancer","volume":"64","author":"Samnick","year":"2006","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.nucmedbio.2004.09.005","article-title":"Radioiodinated phenylalanine derivatives to image pancreatic cancer: a comparative study with [18F]fluoro-2-deoxy-d-glucose in human pancreatic carcinoma xenografts and in inflammation models","volume":"32","author":"Hellwig","year":"2005","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib17","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.4049\/jimmunol.159.6.2645","article-title":"Increased sensitivity of gastric cancer cells to natural killer and lymphokine-activated killer cells by antisense suppression of N-acetylgalactosaminyltransferase","volume":"159","author":"Adachi","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib18","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s00259-003-1445-1","article-title":"p-[123I]Iodo-l-phenylalanine for detection of pancreatic cancer: basic investigations of the uptake characteristics in primary human pancreatic tumour cells and evaluation in in vivo models of human pancreatic adenocarcinoma","volume":"31","author":"Samnick","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib19","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.nucmedbio.2003.12.007","volume":"31","author":"Samnick","year":"2004","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/cncr.10337","article-title":"Clinical utility of indium-111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy","volume":"94","author":"Raj","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.nucmedbio.2005.12.011","article-title":"Comparative in vitro and in vivo evaluation of two 64Cu-labeled bombesin analogs in a mouse model of human prostate adenocarcinoma","volume":"33","author":"Yang","year":"2006","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib22","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ijrobp.2004.05.034","article-title":"Procedure for unmasking localization information from ProstaScint scans for prostate radiation therapy treatment planning","volume":"60","author":"DeWyngaert","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/108497804773391711","article-title":"Role of 99mTc-bombesin scan in diagnosis and staging of prostate cancer","volume":"19","author":"De Vincentis","year":"2004","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib24","first-page":"82","article-title":"Comparative study on the metastatic behavior of human tumors in nude, beige\/nude\/xid and severe combined immunodeficient mice","volume":"13","author":"Garofalo","year":"1993","journal-title":"Invasion Metastasis"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib25","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.1158\/0008-5472.CAN-04-3118","article-title":"Transgenic nude mouse with ubiquitous green fluorescent protein expression as a host for human tumors","volume":"64","author":"Yang","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2006.10.013_bib26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0076-6879(89)73040-8","article-title":"Distinguishing amino acid transport systems of a given cell or tissue","volume":"173","author":"Christensen","year":"1989","journal-title":"Methods Enzymol"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805106002277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805106002277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T09:12:47Z","timestamp":1683709967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805106002277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0969805106002277"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2006.10.013","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}